-+ 0.00%
-+ 0.00%
-+ 0.00%

TEMPUS RECEIVES FDA CLEARANCE FOR ITS ECG-MR AI PRODUCT DESIGNED TO IDENTIFY UNDIAGNOSED MITRAL REGURGITATION

Reuters·09/28/2026 12:00:01

Please log in to view news